Caricamento...
Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy
Currently, a marked number of clinical trials on cancer treatment have revealed the success of immunomodulatory therapies based on immune checkpoint inhibitors that activate tumor-specific T cells. However, the therapeutic efficacy of cancer immunotherapies is only restricted to a small fraction of...
Salvato in:
| Pubblicato in: | Front Immunol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5829092/ https://ncbi.nlm.nih.gov/pubmed/29527212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.00353 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|